Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome
Clinical trial NCT00548587 · COMPLETED
Trial details
- NCT number
- NCT00548587
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.